NCT04402086 Rheumatology Patient Registry and Biorepository
| NCT ID | NCT04402086 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Rheumatic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2020-08-04 |
| Primary Completion | 2030-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2020-08-04 with a primary completion date of 2030-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Eligibility Criteria
Inclusion Criteria for Rheumatology Patients: * Patients ≥18 years old with a diagnosis of a rheumatic autoimmune disease including, but not limited to: adult onset Still's disease, ankylosing spondylitis, antiphospholipid syndrome, Behcet's disease, dermatomyositis, giant cell arteritis, mixed connective tissue disease, polymyalgia rheumatica, polymyositis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren's syndrome, systemic lupus erythematosus, undifferentiated connective tissue disease and vasculitis. * Receiving clinical care at Yale Rheumatology clinics Exclusion Criteria for Rheumatology Patients: * Unable to provide informed consent * No patients will be excluded based on gender or ethnicity or pregnancy status. * Women who are currently pregnant will need to wait to donate a skin biopsy until after they deliver. * Patients allergic to lidocaine or epinephrine or have a history of impaired wound healing will not be able to donate a skin biopsy. Inclusion Criteria for Healthy Volunteers: * Age ≥ 18 years old * No chronic skin conditions * No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis) * Normal BMI Exclusion Criteria for Healthy Volunteers: * Unable to provide informed consent. * Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman. * Allergies to lidocaine or epinephrine (skin biopsies). * A history of impaired wound healing (skin biopsies).
Contact & Investigator
Monique Hinchcliff, MD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT04402086 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Rheumatic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04402086 currently recruiting?
Yes, NCT04402086 is actively recruiting participants. Contact the research team at s.perez@yale.edu for enrollment information.
Where is the NCT04402086 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT04402086 clinical trial?
NCT04402086 is sponsored by Yale University. The principal investigator is Monique Hinchcliff, MD at Yale University. The trial plans to enroll 5,000 participants.